Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer

This paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomarkers of progression-free survival (PFS) in patients...

Full description

Bibliographic Details
Main Authors: Loris De Cecco, Marco Giannoccaro, Edoardo Marchesi, Paolo Bossi, Federica Favales, Laura D. Locati, Lisa Licitra, Silvana Pilotti, Silvana Canevari
Format: Article
Language:English
Published: MDPI AG 2017-01-01
Series:Genes
Subjects:
Online Access:http://www.mdpi.com/2073-4425/8/1/35
id doaj-0bf15f5b99204a44b38c601d00c03486
record_format Article
spelling doaj-0bf15f5b99204a44b38c601d00c034862020-11-24T21:56:02ZengMDPI AGGenes2073-44252017-01-01813510.3390/genes8010035genes8010035Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell CancerLoris De Cecco0Marco Giannoccaro1Edoardo Marchesi2Paolo Bossi3Federica Favales4Laura D. Locati5Lisa Licitra6Silvana Pilotti7Silvana Canevari8Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyFunctional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyFunctional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyLaboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyFunctional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyThis paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomarkers of progression-free survival (PFS) in patients treated with cetuximab-based approaches. Through sparse partial least square–discriminant analysis (sPLS-DA) and supervised analysis, 36 miRNAs were identified in two components that clearly separated long- and short-PFS patients. Gene set enrichment analysis identified a significant correlation between the miRNA first-component and EGFR signaling, keratinocyte differentiation, and p53. Another significant correlation was identified between the second component and RAS, NOTCH, immune/inflammatory response, epithelial–mesenchymal transition (EMT), and angiogenesis pathways. Regularized canonical correlation analysis of sPLS-DA miRNA and gene data combined with the MAGIA2 web-tool highlighted 16 miRNAs and 84 genes that were interconnected in a total of 245 interactions. After feature selection by a smoothed t-statistic support vector machine, we identified three miRNAs and five genes in the miRNA-gene network whose expression result was the most relevant in predicting PFS (Area Under the Curve, AUC = 0.992). Overall, using a well-defined clinical setting and up-to-date bioinformatics tools, we are able to give the proof of principle that an integrative miRNA-mRNA expression could greatly contribute to the refinement of the biology behind a predictive model.http://www.mdpi.com/2073-4425/8/1/35miRNAmicroarrayhead and neck squamous cell carcinomas (HNSCC)cetuximabdrug sensitivity
collection DOAJ
language English
format Article
sources DOAJ
author Loris De Cecco
Marco Giannoccaro
Edoardo Marchesi
Paolo Bossi
Federica Favales
Laura D. Locati
Lisa Licitra
Silvana Pilotti
Silvana Canevari
spellingShingle Loris De Cecco
Marco Giannoccaro
Edoardo Marchesi
Paolo Bossi
Federica Favales
Laura D. Locati
Lisa Licitra
Silvana Pilotti
Silvana Canevari
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
Genes
miRNA
microarray
head and neck squamous cell carcinomas (HNSCC)
cetuximab
drug sensitivity
author_facet Loris De Cecco
Marco Giannoccaro
Edoardo Marchesi
Paolo Bossi
Federica Favales
Laura D. Locati
Lisa Licitra
Silvana Pilotti
Silvana Canevari
author_sort Loris De Cecco
title Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
title_short Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
title_full Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
title_fullStr Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
title_full_unstemmed Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
title_sort integrative mirna-gene expression analysis enables refinement of associated biology and prediction of response to cetuximab in head and neck squamous cell cancer
publisher MDPI AG
series Genes
issn 2073-4425
publishDate 2017-01-01
description This paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomarkers of progression-free survival (PFS) in patients treated with cetuximab-based approaches. Through sparse partial least square–discriminant analysis (sPLS-DA) and supervised analysis, 36 miRNAs were identified in two components that clearly separated long- and short-PFS patients. Gene set enrichment analysis identified a significant correlation between the miRNA first-component and EGFR signaling, keratinocyte differentiation, and p53. Another significant correlation was identified between the second component and RAS, NOTCH, immune/inflammatory response, epithelial–mesenchymal transition (EMT), and angiogenesis pathways. Regularized canonical correlation analysis of sPLS-DA miRNA and gene data combined with the MAGIA2 web-tool highlighted 16 miRNAs and 84 genes that were interconnected in a total of 245 interactions. After feature selection by a smoothed t-statistic support vector machine, we identified three miRNAs and five genes in the miRNA-gene network whose expression result was the most relevant in predicting PFS (Area Under the Curve, AUC = 0.992). Overall, using a well-defined clinical setting and up-to-date bioinformatics tools, we are able to give the proof of principle that an integrative miRNA-mRNA expression could greatly contribute to the refinement of the biology behind a predictive model.
topic miRNA
microarray
head and neck squamous cell carcinomas (HNSCC)
cetuximab
drug sensitivity
url http://www.mdpi.com/2073-4425/8/1/35
work_keys_str_mv AT lorisdececco integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT marcogiannoccaro integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT edoardomarchesi integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT paolobossi integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT federicafavales integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT lauradlocati integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT lisalicitra integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT silvanapilotti integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
AT silvanacanevari integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer
_version_ 1725859958182903808